SUPRIYA

What Supriya Lifescience promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 24 tracked 5 delivered 5 missed 14 open
  • Ambernath Facility Production Start delivered said Q1 FY25 Promised: Start production within the next 60 days Q1 FY27: Successfully launched two new anesthetic liquid inhalation products from the Ambernath facility, confirming operational status.
  • Whey Protein Volume for FY26 missed said Q4 FY25 Promised: ~100 metric tons Q1 FY27: Promise related to FY26, which has been missed. No new updates.
  • Working Capital Days Target at risk said Q4 FY25 Promised: 150-160 days Q1 FY27: Inventory levels are high at Rs. 230-240 crores, built up for a now-deferred maintenance plan. Liquidation will take 3-4 quarters, putting the 170-180 day target at risk.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 24 tracked commitments for Supriya Lifescience — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens